Allergy Therapeutics (AGY)

 

Latest News

All resolutions passed at AGM of Allergy Therapeutics

Allergy Therapeutics has announced that all resolutions were passed by shareholders at today's Annual General Meeting. A...

Result of AGM

RNS Number: 2447X Allergy Therapeutics PLC 22 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Result of Annual General Meeting 22 November 2017 Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, announces that, at its Annual General Meeting held this m...

Block Listing Application

RNS Number: 0383X Allergy Therapeutics PLC 21 November 2017 21 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") Block Listing Application Allergy Therapeutics (AIM:AGY) , the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces that an application has been made to the London Stoc...

Allergy Therapeutics to Present at Jefferies 2017

RNS Number: 2495W Allergy Therapeutics PLC 13 November 2017 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Group") Allergy Therapeutics to Present at Jefferies 2017 London Healthcare Conference 13 November 2017 Allergy Therapeutics plc (AIM:AGY), the fully integrated specialty pharmaceutical group specialising in allergy vaccines, announces th...

All News

DateHeadlineSource
31-05-12Holding(s) in CompanyRNS
23-05-12Voluntary recall of Anapen by Lincoln MedicalRNS
17-05-12Holding(s) in CompanyRNS
17-05-12Holding(s) in CompanyRNS
16-05-12Total Voting RightsRNS
02-05-12Board AppointmentRNS
24-04-12Holding(s) in CompanyRNS
20-04-12Concert Party ShareholdingRNS
20-04-12Director/PDMR ShareholdingRNS
19-04-12Result of AGMRNS
18-04-12Markets: FTSE 100 uncertain on WednesdayInteractive Investor
18-04-12Result of OfferRNS
30-03-12Grant of OptionsRNS
30-03-12Fundraising AnnouncementRNS
30-03-12Half Yearly ReportRNS
14-03-12Notice of results and shareholder updateRNS
21-02-12Holding(s) in CompanyRNS
21-02-12Holding(s) in CompanyRNS
06-12-11Markets: FTSE 100 flat on TuesdayInteractive Investor
08-06-11Regulatory UpdateRNS
28-04-11Total Voting RightsRNS
26-04-11Markets: Manufacturing data lifts FTSE 100Interactive Investor
26-04-11FDA approval lifts shares in Allergy TherapeuticsInteractive Investor
26-04-11FDA UpdateRNS
20-04-11Exercise of OptionsRNS
11-04-11Holding(s) in CompanyRNS
11-04-11Holding(s) in CompanyRNS
07-04-11Grass MATA MPL dossier submitted in SwitzerlandRNS
06-04-11Allergic rhinitis vaccination website launchedRNS
30-03-11Director/PDMR ShareholdingRNS
29-03-11Director/PDMR ShareholdingRNS
29-03-11Director/PDMR ShareholdingRNS
28-03-11Markets: FTSE 100 trims gains on MondayInteractive Investor
28-03-11U.S. regulatory updateRNS
28-03-11Half Yearly ReportRNS
09-02-11Holding(s) in CompanyRNS
09-02-11Holding(s) in CompanyRNS
01-12-10Ten further MAAs submitted inRNS
18-11-10Result of AGMRNS
20-10-10Annual Financial ReportRNS

RSS feeds

  • Editorial news feed for LSE:AGY Editorial
  • Regulatory news feed for LSE:AGY Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account